BIO Asks Congress Not To Subject Biofuels To Double Jeopardy
WASHINGTON, D.C. (Monday, October 05, 2009) - Climate change legislation should not subject biofuels to double jeopardy in greenhouse gas emission regulation, since they are already regulated under the Renewable Fuel Standard. The Biotechnology Industry Organization (BIO) today released a letter to Sen. Barbara Boxer (D-Calif.), chair of the Senate Committee on Environment and Public Works, asking that recently drafted cap-and-trade legislation be amended to clearly state that biofuels, including the biofuel component of fuel blends, are not obligated under the emissions cap.
Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, stated, “When it comes to climate change legislation, Congress has focused a great deal of attention on stationary emission sources, such as coal-fired power plants. We cannot, however, achieve a low-carbon future without biofuels, because biofuels can play a key role in reducing direct CO2 emissions from the transportation sector. While fossil fuels release carbon that has been stored deep underground for millions of years into the atmosphere, biofuels recycle atmospheric carbon. In some cases, biomass production can sequester more carbon in the soil than is released into the atmosphere through biofuel combustion. Biofuels should therefore not be treated in the same manner as fossil fuels under any climate change cap-and-trade legislation.
“Currently drafted legislation to regulate carbon emissions leaves some ambiguity as to whether the biofuels component of fuel blends is counted under the cap. Biofuels are mandated by the federal Renewable Fuel Standard (RFS) to achieve substantial lifecycle greenhouse gas improvements compared to petroleum-based fuels. The performance standards contained in the RFS ensure the climate benefit of future biofuels production. Any effort to place tailpipe emissions of biofuels under the CO2 cap would therefore impose a double greenhouse gas emissions compliance obligation on biofuels.”
Upcoming BIO Events
BIO Investor Forum
October 28-29, 2009
San Francisco, CA
Advanced Business Development Course
October 30, 2009
Vienna, Austria
Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, stated, “When it comes to climate change legislation, Congress has focused a great deal of attention on stationary emission sources, such as coal-fired power plants. We cannot, however, achieve a low-carbon future without biofuels, because biofuels can play a key role in reducing direct CO2 emissions from the transportation sector. While fossil fuels release carbon that has been stored deep underground for millions of years into the atmosphere, biofuels recycle atmospheric carbon. In some cases, biomass production can sequester more carbon in the soil than is released into the atmosphere through biofuel combustion. Biofuels should therefore not be treated in the same manner as fossil fuels under any climate change cap-and-trade legislation.
“Currently drafted legislation to regulate carbon emissions leaves some ambiguity as to whether the biofuels component of fuel blends is counted under the cap. Biofuels are mandated by the federal Renewable Fuel Standard (RFS) to achieve substantial lifecycle greenhouse gas improvements compared to petroleum-based fuels. The performance standards contained in the RFS ensure the climate benefit of future biofuels production. Any effort to place tailpipe emissions of biofuels under the CO2 cap would therefore impose a double greenhouse gas emissions compliance obligation on biofuels.”
Upcoming BIO Events
BIO Investor Forum
October 28-29, 2009
San Francisco, CA
Advanced Business Development Course
October 30, 2009
Vienna, Austria
BIO Europe International Partnering Conference
November 2-4, 2009
Vienna, Austria
Pacific Rim Summit on Industrial Biotechnology and Bioenergy
November 8-11, 2009
Honolulu, HI
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
###